HomeNewsIndiaCOVID-19 | Delhi to launch portal to give Rs 50,000 financial assistance for families of COVID-19 victims - All you need to know

COVID-19 | Delhi to launch portal to give Rs 50,000 financial assistance for families of COVID-19 victims - All you need to know

Delhi's Social Welfare Minister Rajendra Pal Gautam said security checks are currently being conducted on the portal and it will be ready to launch by next Tuesday

June 25, 2021 / 11:46 IST
Story continues below Advertisement
Mukhyamantri COVID-19 Pariwar Aarthik Sahayata Yojana allows families who lost members due to the COVID-19 pandemic to seek ex-gratia of Rs 50,00), CM Arvind Kejriwal had announced on May 18. (Image: ANI)
Mukhyamantri COVID-19 Pariwar Aarthik Sahayata Yojana allows families who lost members due to the COVID-19 pandemic to seek ex-gratia of Rs 50,00), CM Arvind Kejriwal had announced on May 18. (Image: ANI)

Delhi government will launch a portal where families of COVID-19 victims can apply for financial assistance under the Mukhyamantri COVID-19 Pariwar Aarthik Sahayata Yojana (Chief Minister’s COVID-19 Family Financial Assistance Scheme).

Social Welfare Minister Rajendra Pal Gautam said security checks are currently being conducted on the portal and it will be ready to launch by next Tuesday (June 29).

Story continues below Advertisement

Follow our LIVE blog on the COVID-19 pandemic here

Here is all you need to know:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show